Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,20582,31,1.93 [1.17-3.17],0.0096716931551131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,24308,31,3.14 [1.71-5.75],0.0002127585098592
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,24057,32,3.94 [1.51-10.26],0.0049470328478002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,24683,31,2.04 [1.42-2.92],0.0001081797323648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,21151,30,3.75 [1.92-7.31],0.0001051795223209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,21151,30,3.20 [1.93-5.30],6.061497554189495e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,24580,31,8.81 [3.90-19.91],1.6970710215427133e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,24644,33,5.85 [3.10-11.05],5.218990146830063e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,24414,31,0.32 [0.15-0.72],0.0058480993236011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,20653,27,4.24 [2.66-6.76],1.1792630661059788e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,24781,33,7.76 [2.00-30.15],0.0030846036940362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",21211,31,2.06 [1.25-3.39],0.00447935199787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,20357,27,1.98 [1.53-2.56],2.443334915970262e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24367,31,2.13 [1.47-3.07],5.616140081822081e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,24639,30,2.65 [1.86-3.77],6.211280977881961e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,21268,30,2.71 [1.39-5.31],0.0035690523046957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,21268,30,2.33 [1.41-3.85],0.0009698181390458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,21226,30,2.48 [1.34-4.59],0.0037230944715944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,20271,30,1.90 [1.32-2.73],0.000583910175899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,21268,30,1.50 [1.20-1.86],0.000329539906812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,23902,31,1.98 [1.45-2.72],2.223331992459741e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,21151,30,1.77 [1.25-2.50],0.0011486090649993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,24543,31,4.53 [1.82-11.32],0.0011988151337723
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,21211,31,2.03 [1.24-3.33],0.0047569885944832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,21268,30,1.83 [1.35-2.49],9.378680212729744e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",24580,31,14.00 [6.91-28.40],2.5206925127401084e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,20637,31,2.32 [1.54-3.51],6.222654375384097e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,23902,31,2.78 [1.34-5.76],0.0060420864387689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,21187,31,1.99 [1.66-2.39],1.9034658721032746e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,21151,30,2.79 [2.24-3.48],9.802920505875064e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,20637,31,4.06 [3.24-5.08],5.4531982460289195e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20637,31,3.54 [2.43-5.15],4.386606796809229e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BSG,Basigin,24737,31,12.03 [3.51-41.28],7.634097330474651e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,24721,31,2.00 [1.41-2.84],0.0001097901328557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,24580,31,8.57 [3.75-19.60],3.518618703628531e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,24477,32,2.82 [1.75-4.55],2.278923446575616e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,23909,30,1.55 [1.13-2.12],0.0062269541979944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,24655,31,8.48 [3.03-23.74],4.769580421254399e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,21232,30,11.97 [2.37-60.42],0.0026530240849883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,21187,31,3.55 [2.71-4.64],2.469652686431669e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,20653,27,2.07 [1.35-3.16],0.0007775102459161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,24429,32,31.46 [8.04-123.00],7.161372775605688e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,24332,29,2.03 [1.35-3.06],0.0006645702382267
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,20656,27,2.54 [1.56-4.15],0.0001841705400655
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,21211,31,1.69 [1.34-2.13],8.094756147218933e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,24477,32,1.55 [1.28-1.88],8.551846461239034e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,24492,31,1.51 [1.12-2.02],0.0061677558445177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,23934,30,2.41 [1.24-4.66],0.0091927389760878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,24543,31,2.52 [1.34-4.73],0.0039836226007832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,24441,30,1.65 [1.20-2.25],0.0017785396143077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,24477,32,5.30 [3.86-7.28],7.832902354130343e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,24785,31,6.97 [4.61-10.54],3.1808221581117763e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,24535,32,8.13 [5.24-12.60],7.930402504251332e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,23902,31,3.66 [2.28-5.89],8.898267494897322e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,24629,30,3.54 [1.85-6.78],0.0001411480813715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,24433,32,2.33 [1.28-4.24],0.005838478961439
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,24298,31,3.39 [1.94-5.93],1.880063987390035e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,24545,31,22.09 [12.81-38.11],8.980091244970271e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,24673,30,8.85 [6.25-12.55],1.4240968643448482e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,23567,32,3.92 [1.62-9.49],0.0025155459326283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,24737,31,4.62 [2.69-7.93],2.7957066729405642e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,24477,32,6.33 [4.48-8.93],9.191588131409528e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,20765,30,8.15 [5.59-11.90],1.455361499725191e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,24721,31,17.38 [10.57-28.57],2.1175616653163448e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,24785,31,1.77 [1.38-2.26],7.275704079699053e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,24477,32,11.10 [5.52-22.32],1.4445416941112279e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,21151,30,4.79 [1.74-13.16],0.0024096014153382
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,24721,31,5.94 [3.33-10.57],1.4720584742595728e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,23864,32,1.73 [1.16-2.59],0.0074575112336122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,24367,31,0.41 [0.22-0.75],0.0039231988764365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,20765,30,0.32 [0.17-0.61],0.0005960607098003
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21187,31,1.99 [1.41-2.80],9.462800829739768e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,21126,29,2.64 [1.52-4.58],0.0005583854300317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,21235,30,2.30 [1.30-4.06],0.0041520016719455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,20637,31,3.25 [1.70-6.23],0.0003711280693629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,24057,32,3.65 [1.67-7.99],0.0012084954985894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,24477,32,2.94 [1.73-4.99],6.22343703070835e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,23902,31,2.33 [1.35-4.01],0.0022442278297548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,21187,31,3.93 [2.56-6.05],4.0433375191514366e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,21268,30,2.03 [1.33-3.09],0.0010327275910773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,24477,32,2.60 [1.47-4.60],0.0009901972453092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,21243,30,3.52 [2.08-5.95],2.723625849470625e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,24559,32,5.56 [1.54-20.07],0.0087178045212889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,24498,32,3.14 [1.67-5.90],0.0003852971784625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,20842,28,1.78 [1.29-2.45],0.0004332154002312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",20653,27,2.09 [1.34-3.25],0.0010985616308872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,21164,31,5.37 [2.26-12.76],0.00013802155268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,24543,31,3.19 [1.88-5.42],1.666672898698077e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,23861,31,1.63 [1.17-2.27],0.003775773734898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,24580,31,7.56 [2.62-21.77],0.0001803003725528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,24580,31,4.87 [1.47-16.12],0.0095061910804259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,24330,31,5.41 [3.24-9.01],9.510974993184579e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,24580,31,7.84 [3.10-19.79],1.3201896650406563e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,21249,31,2.73 [1.75-4.25],1.011541981071728e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,24142,33,2.64 [1.61-4.30],0.00010646582826
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,22820,29,2.23 [1.35-3.69],0.0017585865805964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,23990,32,1.98 [1.31-2.98],0.001139169647842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,24498,32,5.94 [2.27-15.58],0.0002920413842714
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,19345,25,9.89 [2.78-35.19],0.000404978856092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,24451,31,3.97 [1.60-9.87],0.0030155142609055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,21034,30,2.15 [1.69-2.73],5.001888135276321e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,24721,31,1.54 [1.14-2.08],0.0047573004879265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,24721,31,1.75 [1.40-2.19],8.787679920168024e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,24580,31,2.05 [1.53-2.74],1.1964416725577151e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,20897,30,3.16 [2.31-4.33],7.986570517089918e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,24360,30,1.73 [1.19-2.53],0.0044466927949548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,24498,32,7.46 [3.86-14.44],2.3986791816235e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,20582,31,2.12 [1.38-3.28],0.0006601907846628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,24721,31,7.25 [3.69-14.23],8.773839447637464e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,20637,31,3.21 [1.62-6.38],0.0008622763231288
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,23902,31,1.66 [1.21-2.28],0.0015896331415396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,24785,31,1.77 [1.18-2.65],0.0054313893004098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,20590,31,2.20 [1.68-2.88],1.159999084653694e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,21126,29,2.52 [1.87-3.40],1.1820207737899304e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,24535,32,5.47 [2.25-13.30],0.0001775749165956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,20653,27,2.29 [1.56-3.36],2.385232218945029e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,24330,31,2.80 [2.05-3.83],1.1851334998975934e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,24367,31,4.40 [2.06-9.36],0.0001227378055397
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,24639,30,2.24 [1.68-3.00],4.2475718328904745e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,21211,31,5.86 [2.68-12.78],8.943345392408143e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,21090,29,2.23 [1.40-3.57],0.0007785151445677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,24367,31,6.65 [3.80-11.61],2.902933309486769e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,21187,31,3.22 [1.76-5.89],0.0001481427235531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,24672,30,4.36 [2.45-7.75],5.186391178350604e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",20653,27,1.60 [1.14-2.25],0.0067531429393766
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,24704,30,2.91 [1.37-6.19],0.0056122190031598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,20653,27,4.26 [1.81-10.05],0.0009236082583278
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21151,30,2.52 [1.39-4.57],0.0022798339328989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,21211,31,2.17 [1.26-3.72],0.0049760687776369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,24432,30,5.26 [2.33-11.88],6.672348603747502e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,24289,31,9.58 [6.40-14.36],5.927561478537825e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,24477,32,2.03 [1.68-2.46],2.312774800492354e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,24367,31,2.34 [1.94-2.81],2.379069507228385e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,20582,31,2.00 [1.20-3.34],0.0077646500740952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,24057,32,7.48 [1.98-28.24],0.0029720428019286
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,20653,27,2.57 [1.86-3.55],9.214370226321666e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,20637,31,2.26 [1.26-4.03],0.0059420119681682
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,23612,31,5.15 [2.70-9.83],6.700039729991723e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,20765,30,6.44 [2.11-19.69],0.0010943107234608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,24781,33,4.41 [1.73-11.22],0.0018597695189827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,24283,31,5.11 [2.04-12.80],0.0004892390121353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,24671,30,1.63 [1.17-2.27],0.003624461154394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,24535,32,0.32 [0.14-0.71],0.0048956626025895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,24721,31,24.51 [13.83-43.42],5.744413051039059e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",24460,31,1.63 [1.23-2.16],0.0007607526751379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",24498,32,1.66 [1.18-2.34],0.0036724187072912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",21243,30,1.93 [1.22-3.04],0.0046449663927964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,24470,32,4.03 [1.57-10.33],0.0037387097436158
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,21243,30,2.87 [2.05-4.02],8.099264057435104e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,21211,31,2.99 [1.33-6.74],0.0081639967531422
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,24476,30,3.78 [3.14-4.56],1.4057661342922778e-44
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23902,31,1.78 [1.21-2.61],0.0034075257704069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,24498,32,7.03 [5.01-9.87],1.5969910228998654e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,24678,31,5.23 [4.19-6.52],9.657862098385768e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,24040,30,5.93 [4.57-7.69],4.704588902991389e-41
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,24476,30,6.21 [3.89-9.92],1.9915388863961488e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,23902,31,2.05 [1.61-2.62],6.7149371487931e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,23902,31,1.59 [1.29-1.97],1.994034699245908e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,24477,32,1.72 [1.15-2.56],0.0079075233340279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,23902,31,2.16 [1.27-3.66],0.0042649011960223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,20637,31,2.38 [1.63-3.49],8.092429514245102e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,24477,32,1.84 [1.33-2.57],0.0002840547373952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,20653,27,6.25 [1.87-20.89],0.0029147000464575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,23864,31,4.12 [2.86-5.94],2.829901122584413e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24721,31,2.44 [1.26-4.74],0.0082426874609241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,24040,30,5.10 [3.13-8.32],6.288069872782519e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,24367,31,6.08 [1.93-19.17],0.0020519002800795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,21148,31,2.40 [1.75-3.31],7.872192893324704e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,24040,30,1.79 [1.25-2.57],0.0016334237972617
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20255,30,2.40 [1.74-3.29],6.921948655411787e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,23868,31,2.65 [1.49-4.74],0.0009682604670089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,24672,30,7.13 [2.75-18.47],5.189711929388272e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,24024,29,2.40 [1.29-4.48],0.0059343994301009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,21187,31,3.82 [1.60-9.09],0.0024552762148248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,21126,29,1.86 [1.35-2.56],0.0001529252861828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,20733,30,2.06 [1.43-2.96],9.803543736618569e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,21211,31,1.97 [1.40-2.77],0.0001059989984423
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",21235,30,2.01 [1.20-3.38],0.0081773878409612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,23909,30,2.83 [1.91-4.21],2.5346006965609624e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,24357,30,7.96 [5.06-12.54],3.4188882239040803e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",24367,31,1.67 [1.14-2.46],0.0090034730804604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,24785,31,2.81 [1.61-4.92],0.0002828105533986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,24057,32,1.42 [1.12-1.80],0.0042932091661941
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,24673,30,2.27 [1.51-3.42],7.702977858298335e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,24476,30,5.01 [2.72-9.24],2.3309763500478255e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,21187,31,2.64 [1.99-3.50],1.5787456192024172e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,21187,31,1.99 [1.32-3.02],0.0010835356117532
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,21153,31,1.68 [1.27-2.22],0.0002609314163699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",21211,31,4.94 [1.63-14.93],0.0046634915352767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",24394,32,3.14 [1.59-6.21],0.001026750589882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24477,32,6.08 [3.18-11.63],4.9880115703717455e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,24223,32,2.32 [1.36-3.95],0.0019170542776973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,23909,30,2.28 [1.67-3.11],2.351505587649294e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,23971,32,1.86 [1.33-2.59],0.0002709615852464
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,21211,31,2.71 [1.54-4.80],0.0005897492532758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,24781,33,6.00 [1.61-22.38],0.0076531044291644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,24353,31,4.47 [1.98-10.06],0.0003049674046588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,24781,33,24.05 [14.80-39.09],1.0051830584713217e-37
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,24367,31,21.33 [4.54-100.09],0.0001049909050006
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20673,30,5.31 [3.25-8.66],2.3502062075130683e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,24580,31,3.56 [1.81-7.01],0.0002359266374962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,23909,30,2.09 [1.31-3.32],0.0019276462361816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,24477,32,3.05 [2.27-4.11],1.5777116170303236e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,21237,30,2.19 [1.29-3.71],0.0036924300111317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,24367,31,3.87 [3.14-4.77],9.2583695124031e-37
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,24040,30,1.67 [1.35-2.07],2.3186332722500006e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,24580,31,3.58 [2.32-5.53],9.517397847764551e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,24367,31,2.61 [1.87-3.65],1.5373904243515618e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,24785,31,4.52 [2.64-7.74],3.68592882276476e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,24040,30,4.86 [2.94-8.03],6.95201908406482e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,24040,30,6.51 [3.37-12.58],2.499678983531016e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,24785,31,2.99 [2.15-4.15],6.630584137860951e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,24161,32,2.13 [1.22-3.74],0.008163539560058
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,24543,31,6.91 [4.05-11.82],1.5442238503475948e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,24432,30,4.34 [1.96-9.57],0.0002814849617067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,24320,33,4.87 [3.53-6.72],4.049967818368248e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,21126,29,2.15 [1.52-3.03],1.5894020125973574e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,24477,32,5.01 [3.34-7.52],6.3737012943576495e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,24477,32,0.36 [0.20-0.65],0.0007897940668282
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,24306,31,4.05 [1.69-9.74],0.0017526812978872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,24476,30,0.47 [0.26-0.82],0.0084183824192057
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23874,30,1.86 [1.42-2.44],6.859993001731764e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,21126,29,2.09 [1.43-3.06],0.0001484216157339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,23862,30,2.32 [1.79-2.99],1.3745087436818554e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,20765,30,2.39 [1.33-4.30],0.0036998463865551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20653,27,4.26 [2.77-6.57],5.2265053377964605e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",24057,32,1.84 [1.46-2.32],2.9611664261692605e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,20637,31,4.02 [1.94-8.34],0.0001783726636959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,24331,33,2.50 [1.25-4.99],0.0096345172384713
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,24543,31,3.12 [1.39-7.01],0.0058673062108997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,24040,30,2.05 [1.28-3.29],0.0029965986615107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,24040,30,1.61 [1.17-2.21],0.0033309431391206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,24367,31,3.07 [1.50-6.26],0.0020988430472538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,20771,30,2.30 [1.80-2.93],1.994651743004528e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,21126,29,1.80 [1.21-2.68],0.0036051023377441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23902,31,1.75 [1.18-2.58],0.0050081677904414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,20590,31,2.11 [1.34-3.31],0.0011852062783312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,24785,31,4.16 [1.98-8.78],0.0001772697409781
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,24448,32,2.13 [1.35-3.37],0.0011833822761409
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,24367,31,2.90 [2.21-3.81],1.7603106576495294e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24460,31,2.79 [1.72-4.51],3.02009588659009e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,24283,31,3.49 [1.73-7.04],0.0004672837202987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,21211,31,2.21 [1.46-3.35],0.0001850803810468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,21268,30,2.75 [1.54-4.93],0.0006709584841883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,24460,31,1.99 [1.21-3.27],0.0069257280446878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,24457,31,7.99 [3.98-16.02],4.7889692725465166e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24781,33,13.80 [5.89-32.31],1.4822298521470074e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24644,33,6.29 [3.04-12.98],6.814456158805001e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,24040,30,5.13 [2.83-9.30],7.118127547885643e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,21106,30,1.67 [1.25-2.23],0.0004650854094121
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,21187,31,4.69 [2.58-8.52],4.017439006804096e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,20582,31,1.70 [1.16-2.48],0.0061783079065574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,21268,30,4.61 [2.16-9.87],8.163960062125538e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,24367,31,2.69 [1.72-4.21],1.5606709228337042e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,21151,30,9.43 [4.59-19.35],9.70523103525959e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,21126,29,2.16 [1.24-3.77],0.0067545781335189
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,24477,32,6.62 [4.22-10.38],1.925692409730375e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,24477,32,3.46 [2.49-4.79],1.0414088000634685e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,24321,31,3.71 [1.47-9.35],0.0054499427067658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,24477,32,7.61 [3.13-18.52],7.787244301658203e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,24248,29,38.99 [21.49-70.74],1.875477491052712e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,23902,31,1.89 [1.58-2.27],7.35563166011222e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,23902,31,1.78 [1.28-2.47],0.0005649618579042
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,24252,31,2.14 [1.71-2.68],3.233654214581202e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20653,27,20.36 [6.97-59.51],3.6428792860032026e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,21187,31,3.87 [2.66-5.63],1.6596596386026885e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,20488,28,1.83 [1.20-2.80],0.0048039425577646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,24498,32,9.47 [2.93-30.62],0.0001741281495244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,24785,31,6.33 [2.18-18.40],0.0006885622633023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,24040,30,2.59 [1.59-4.21],0.0001291477186615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,24527,29,2.51 [1.54-4.11],0.000248383485019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,21187,31,2.07 [1.28-3.33],0.0029068831095856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,24057,32,1.60 [1.13-2.27],0.0082053623614691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,21211,31,1.93 [1.47-2.53],1.953672451693849e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,21126,29,2.29 [1.65-3.18],6.652054820934542e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,20615,27,3.00 [1.88-4.78],4.1420441370511886e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,24040,30,2.17 [1.80-2.62],5.969666384063258e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,24470,32,4.14 [1.74-9.85],0.0013038106084927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",24477,32,1.65 [1.22-2.22],0.0010255245255869
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,20582,31,2.16 [1.43-3.26],0.0002323381346418
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,23902,31,3.95 [2.76-5.66],7.7783722748743e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,20582,31,2.69 [1.94-3.73],2.981936157437038e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,21187,31,3.68 [2.22-6.10],4.683011382849509e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,20282,30,9.08 [3.09-26.64],5.921873185798122e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,24330,31,1.90 [1.60-2.26],3.0755606594368174e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",23909,30,2.13 [1.60-2.84],2.1402041915236346e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,24781,33,37.63 [14.59-97.10],6.309676582273362e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,20884,30,3.12 [1.83-5.31],2.804038235652671e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,24498,32,2.75 [1.43-5.30],0.0024939791249142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,24498,32,6.19 [2.64-14.54],2.8536311340275835e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,24476,30,3.70 [1.93-7.08],7.933024938930891e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,21187,31,2.03 [1.19-3.46],0.009511732103379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,20582,31,2.55 [1.60-4.06],8.006500823687033e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,21211,31,4.19 [2.68-6.55],3.29575271743669e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,24367,31,6.13 [3.16-11.88],7.841927014286765e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,21187,31,2.68 [1.50-4.79],0.0008302000784294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,24477,32,1.72 [1.46-2.04],2.7433911421978246e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,21151,30,12.86 [5.83-28.41],2.6170804790924317e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,24669,30,8.49 [5.80-12.45],5.115101857090906e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",21211,31,1.72 [1.17-2.54],0.005910093400134
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24477,32,3.24 [2.27-4.61],6.898610224613006e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24476,30,6.22 [3.12-12.39],1.995055028277226e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,24535,32,3.92 [1.46-10.53],0.0068228069003399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,24296,31,4.13 [1.51-11.30],0.005780022750898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,21187,31,1.87 [1.21-2.90],0.0051290869901946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,20590,31,2.35 [1.67-3.32],1.122062656132799e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,20637,31,1.88 [1.19-2.97],0.006675339029312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24367,31,3.10 [2.34-4.10],2.1535750483352864e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,23902,31,2.05 [1.65-2.54],8.262811223680702e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,21235,30,0.40 [0.22-0.74],0.0032454742488715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23902,31,2.34 [1.67-3.28],9.23776260274344e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,20653,27,4.39 [2.24-8.61],1.7082195407508893e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,21044,30,2.74 [1.36-5.52],0.0048086031402089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,24477,32,1.95 [1.59-2.39],9.474872852024564e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,24275,31,3.71 [1.93-7.15],8.833549057776596e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,24057,32,1.92 [1.18-3.12],0.0087893583854057
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,24330,31,1.95 [1.37-2.76],0.0002020287893271
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,21235,30,2.44 [1.44-4.13],0.0008915401496448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,21151,30,2.24 [1.34-3.74],0.0020303443118703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,20827,30,1.63 [1.13-2.34],0.0087737672100901
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,24040,30,0.38 [0.21-0.69],0.0015001207334835
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,21126,29,2.08 [1.56-2.79],7.77335174438631e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,23902,31,1.90 [1.55-2.34],1.0977062455428692e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,21211,31,2.07 [1.34-3.19],0.0009556879201081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,20582,31,2.21 [1.65-2.96],1.1839879177625769e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,24367,31,2.04 [1.30-3.19],0.0018367649638023
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,24476,30,8.50 [4.12-17.53],6.761265589558802e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20765,30,2.14 [1.25-3.68],0.0058934913959116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,21093,29,2.76 [1.85-4.11],6.537152105128541e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,24660,32,4.62 [2.38-8.93],5.625431314840229e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,20653,27,5.98 [2.65-13.47],1.6230744570471083e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,24498,32,7.13 [2.87-17.71],2.2905060109634872e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,23902,31,1.86 [1.40-2.47],1.5989426940363853e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23902,31,1.83 [1.19-2.83],0.006092519875086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,24704,30,2.20 [1.43-3.38],0.000319519377243
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,20637,31,2.79 [1.52-5.10],0.0008823976820545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,21268,30,1.75 [1.15-2.67],0.0094693053689823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,21211,31,3.36 [2.24-5.04],4.3020217066755516e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,20582,31,2.34 [1.91-2.86],1.192805811809594e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,24367,31,1.87 [1.33-2.63],0.0003367280091562
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,23863,31,3.79 [1.86-7.74],0.0002485062571644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,24641,30,2.39 [1.38-4.13],0.0018948153417974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,24498,32,2.50 [1.53-4.09],0.0002426187809474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,20765,30,2.09 [1.53-2.87],3.9893515600806535e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,21268,30,8.58 [5.48-13.42],4.75259698541524e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,20765,30,2.58 [1.46-4.55],0.0010658628048792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,24367,31,2.24 [1.41-3.55],0.0006243823477561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,24721,31,4.97 [1.72-14.32],0.0029985829280883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,24691,33,7.54 [5.34-10.64],1.1931487593260856e-30
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,21139,31,2.88 [1.43-5.78],0.0029801188205546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,24367,31,3.41 [1.89-6.12],4.275384154468916e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,24785,31,1.77 [1.36-2.29],1.6912425556832683e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,24253,31,4.85 [2.79-8.43],2.1037851380320485e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,21235,30,3.42 [1.89-6.18],4.786628514591563e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,24580,31,4.17 [2.53-6.87],2.1329778031260107e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24477,32,2.26 [1.65-3.10],4.068650424431592e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,24704,30,4.43 [3.22-6.10],7.160958273481181e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,24498,32,3.62 [1.42-9.22],0.007031181053974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,20653,27,6.48 [3.57-11.77],8.336400273371928e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,24409,31,2.46 [1.25-4.82],0.0089912953815726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,24040,30,2.98 [1.77-5.01],3.66821879257979e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,23902,31,4.76 [3.70-6.13],7.2654242107869445e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,23902,31,4.44 [2.92-6.76],3.3859303797220325e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,24704,30,3.13 [1.36-7.21],0.0073546628811861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',21187,31,2.07 [1.71-2.51],1.147121614482627e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,20582,31,1.87 [1.47-2.37],2.5577239947167865e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,23902,31,3.07 [1.34-7.07],0.0082941816401301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,24389,30,4.65 [2.82-7.67],1.814038863228689e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",20590,31,2.56 [1.63-4.02],4.094177832530667e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,24367,31,2.70 [2.03-3.59],1.0531453582289787e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,24477,32,1.63 [1.22-2.18],0.000888854837531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,20637,31,1.76 [1.19-2.60],0.0048931334123147
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,24721,31,7.26 [5.11-10.34],3.173453635436368e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,20637,31,3.68 [1.99-6.78],3.161420758905649e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,21151,30,2.68 [1.57-4.57],0.0002893671173556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,24477,32,1.78 [1.28-2.47],0.0005672187570037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,21126,29,2.14 [1.26-3.64],0.0050636497856831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,21151,30,2.64 [2.11-3.30],2.920227507530921e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,21187,31,3.00 [2.11-4.26],8.955986158847843e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,24285,31,2.67 [2.14-3.33],1.990627743676524e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,21243,30,4.02 [3.02-5.36],1.930998291365993e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,21126,29,1.76 [1.37-2.26],9.94457970369158e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,24452,32,1.86 [1.36-2.53],0.0001012396307739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,24535,32,3.05 [1.42-6.54],0.0041524915805299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,21249,31,5.08 [1.56-16.55],0.0069198232904183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,24498,32,9.10 [4.01-20.70],1.3510007381365528e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,24472,31,0.39 [0.20-0.76],0.0055967882221409
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,24399,32,3.28 [1.55-6.95],0.0019235532521478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23862,30,2.09 [1.33-3.28],0.0014010262504325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,24543,31,2.50 [1.27-4.94],0.0081413219817644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,24424,32,5.81 [1.74-19.41],0.004210303985583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,20637,31,3.82 [1.62-9.01],0.0022405194711872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,24367,31,0.60 [0.41-0.87],0.0075765972406904
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,24476,30,2.15 [1.47-3.15],8.626828758866498e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,24016,32,2.13 [1.62-2.81],8.021398436952269e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24330,31,1.61 [1.29-2.02],2.62092883655964e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24504,31,5.38 [3.94-7.35],3.543251998059463e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,24040,30,3.77 [3.04-4.66],3.7135831123891884e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24504,31,4.42 [1.87-10.45],0.0007095326937996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20765,30,9.25 [5.08-16.82],3.1614032388078544e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24704,30,3.25 [1.42-7.45],0.0053849663880364
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24476,30,4.87 [2.15-11.03],0.0001456980193174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,24721,31,3.99 [1.40-11.38],0.0097076181024645
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24737,31,9.68 [5.84-16.06],1.4386886420173817e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24330,31,1.80 [1.18-2.75],0.0067048996559547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24721,31,3.88 [2.63-5.75],1.1041987793667878e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24330,31,5.33 [4.30-6.60],5.929241895743682e-53
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,21235,30,5.26 [2.94-9.40],2.2084828244906607e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,21187,31,1.82 [1.31-2.53],0.0003444267578076
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,20637,31,1.88 [1.34-2.64],0.0002367292291151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,20653,27,1.73 [1.19-2.51],0.0043212357611171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,23902,31,2.36 [1.80-3.10],5.63231431765772e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,20637,31,2.01 [1.44-2.80],4.012099112913919e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,21243,30,5.19 [1.74-15.48],0.0031596535011539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,20582,31,1.90 [1.47-2.46],9.15747235138954e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",20637,31,1.82 [1.17-2.84],0.0082269073392828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,24476,30,8.31 [5.14-13.45],6.573844178679103e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,20892,29,1.93 [1.18-3.16],0.0087593048717166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,24695,33,0.51 [0.32-0.81],0.0047314337388559
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,21126,29,2.00 [1.26-3.16],0.003156521749125
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,21187,31,1.68 [1.26-2.24],0.0004661718465269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,24514,31,12.54 [6.70-23.49],2.786718379202055e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,21126,29,1.94 [1.20-3.16],0.0073054118197706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,24438,30,3.70 [2.03-6.76],2.0158419726340763e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",24476,30,2.96 [1.35-6.49],0.0066028254933442
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,21126,29,1.89 [1.42-2.52],1.1172274681010112e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,23198,30,3.00 [1.66-5.41],0.0002592636335279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,24704,30,1.82 [1.32-2.50],0.0002311057330081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,21187,31,5.60 [2.78-11.28],1.402024998009433e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,21126,29,3.96 [2.19-7.17],5.346350309380438e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,20637,31,2.81 [2.11-3.75],1.7176881294800928e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,24057,32,2.96 [2.24-3.90],1.6553914453750838e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,21187,31,3.12 [2.50-3.90],1.94265521489182e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,21151,30,2.27 [1.56-3.31],1.8944793952211376e-05
